MTOR and non-small cell lung carcinoma: In non-small-cell lung cancer (NSCLC) models, the overexpression of Sirtuin 6 (SIRT6) downregulates p-PI3K, p-AKT, and p-mTOR levels, significantly inhibiting the expression of the proliferation marker Ki-67.